SARS-CoV-2 Clinical Characteristics and Viral Shedding in Kuwait
Affiliations
Affiliations
- Department of Pediatrics, Amiri Hospital, Ministry of Health, Kuwait, Kuwait.
- McGill University Health Centre Research Institute, Montreal, Québec, Canada.
- Department of Pediatrics, Jaber Alahmad Hospital, Ministry of Health, Kuwait, Kuwait.
- Department of Medicine, Infectious Diseases Hospital, Ministry of Health, Kuwait, Kuwait.
- Division of Pediatric Infectious Diseases, The Montreal Children's Hospital, McGill University Health Centre, Montreal, Québec, Canada.
- Division of Microbiology, Department of Laboratory Medicine, McGill University Health Centre, Montreal, Québec, Canada.
Abstract
Objectives: We aimed to describe the clinical characteristics of SARS-CoV-2 infection and estimate viral shedding duration in respiratory specimens.
Methods: A retrospective cohort study was performed from February 25 to March 25, 2020. In Kuwait, all suspected coronavirus disease 2019 (COVID-19) cases, contacts of cases, and returning travelers were systematically tested for SARS-CoV-2 by RT-PCR. All infected persons, regardless of symptoms, were hospitalized and serially tested until they had two negative results. Descriptive statistics and regression analyses were performed.
Results: Two hundred seven cases of SARS-CoV-2 infection were included in this study. About half of the cases were asymptomatic and 1.9% died. The median time to negative RT-PCR was 22 days. Increasing age, ARDS, and low peripheral white blood cell count were associated with prolonged PCR positivity.
Conclusion: Predictors for prolonged RT-PCR positivity included increasing age, ARDS, and low white blood cell count. The findings of this study may aid in better understanding of the epidemiology of SARS-CoV-2 infection and molecular testing dynamics.
Keywords: Coronavirus disease-19; Epidemiology; Hospitalization; Severe acute respiratory syndrome-related coronavirus-2; Shedding.
Conflict of interest statement
J.P. has received consulting/honoraria fees from AbbVie, Cepheid, and Seegene and research grant funding outside of the current study from AbbVie, BD Diagnostics, Sanofi Pasteur, and MedImmune.
Similar articles
Alsharrah D, Alhaddad F, Alyaseen M, Aljamaan S, Almutairi N, Ayed M, Papenburg J, Alghounaim M.J Med Virol. 2021 May;93(5):3246-3250. doi: 10.1002/jmv.26684. Epub 2020 Dec 1.PMID: 33219559 Free PMC article.
Dynamic profile of SARS-CoV-2 infection among hospitalized patients in Kuwait: a descriptive study.
Madi N, Al-Awadhi E, Al-Assaf F.BMC Infect Dis. 2021 Aug 5;21(1):758. doi: 10.1186/s12879-021-06504-x.PMID: 34353284 Free PMC article.
Wang K, Zhang X, Sun J, Ye J, Wang F, Hua J, Zhang H, Shi T, Li Q, Wu X.Chest. 2020 Nov;158(5):1876-1884. doi: 10.1016/j.chest.2020.06.015. Epub 2020 Jun 20.PMID: 32569635 Free PMC article.
Lewis NM, Duca LM, Marcenac P, Dietrich EA, Gregory CJ, Fields VL, Banks MM, Rispens JR, Hall A, Harcourt JL, Tamin A, Willardson S, Kiphibane T, Christensen K, Dunn AC, Tate JE, Nabity S, Matanock AM, Kirking HL.Emerg Infect Dis. 2021 Feb;27(2):352-359. doi: 10.3201/eid2702.203517. Epub 2020 Dec 4.PMID: 33275874 Free PMC article. Review.
Nationwide study of rates of reinfection with SARS-CoV-2 among adults in Kuwait.
Al-Ahmad M, Alowayesh M, Al Awadi A, Alghounaim M, Al Hashemi H, Al Enezi L, Rawdhan H, Rodriguez-Bouza T.East Mediterr Health J. 2023 Feb 26;29(2):146-150. doi: 10.26719/emhj.23.015.PMID: 36880496 Review.
KMEL References
References
-
- World Health Organization . Clinical management of severe acute respiratory infection when COVID-19 is suspected: interim guidance V12. 2020. Available from: https://www.who.int/publications/i/item/clinical-management-of-covid-19.
-
- Wong JEL, Leo YS, Tan CC. COVID-19 in Singapore-current experience: critical global issues that require attention and action. JAMA. 2020;323((13)):1243. - PubMed